Turkey’s Leading University Hospital Adopts Masimo Corporation SpHb For Continuous Noninvasive Haemoglobin Monitoring

NEUCHÂTEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that Turgut Ozal Medical Centre Liver Hospital in Malatya, Turkey, has installed Masimo’s noninvasive, continuous haemoglobin (SpHb®) technology to monitor surgical patients.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC